Cost-Utility of Certolizumab Pegol for The Treatment of Axial Spondyloarthritis In Greece

Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2304
https://www.valueinhealthjournal.com/article/S1098-3015(15)04380-6/fulltext
Section Title : Research Podium Presentations - Session 1 and Session 2
Section Order : 1717
First Page : A644
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04380-6&doi=10.1016/j.jval.2015.09.2304
HEOR Topics :
Tags :
Regions :